New immunosuppressive drugs in dermatology (Mycophenolate mofetil, tacrolimus): Unapproved uses, dosages, or indications

被引：16
|
作者：
Assmann, T [1 ]
Ruzicka, T [1 ]
机构：
[1] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany
来源：
CLINICS IN DERMATOLOGY | 2002年 / 20卷 / 05期
关键词：
D O I：
10.1016/S0738-081X(02)00271-7
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：505 / 514
页数：10
相关论文
共 50 条
  • [21] Drug concentration monitoring of immunosuppressive agents - Focus on tacrolimus, mycophenolate mofetil and sirolimus
    Tsunoda, SM
    Aweeka, FT
    BIODRUGS, 2000, 14 (06) : 355 - 369
  • [22] MYCOPHENOLATE MOFETIL AND BREQUINAR SODIUM - NEW IMMUNOSUPPRESSIVE AGENTS
    HULLETT, DA
    SOLLINGER, HW
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (03) : 45 - 47
  • [23] Comparative study of cyclosporin A and tacrolimus versus newer immunosuppressive drugs mycophenolate mofetil and rapamycin on coronary endothelial function in vitro
    Jeanmart, H
    Cartier, R
    Carrier, M
    Perrault, LP
    CIRCULATION, 2000, 102 (18) : 764 - 764
  • [24] Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and Immunosuppressive Drugs: Causality of Mycophenolate Mofetil or Tacrolimus?
    Loustaud-Ratti, Veronique
    Anneraud, Alicia
    Carrier, Paul
    Debette-Gratien, Marilyne
    De Muret, Anne
    Tallegas, Mattias
    Barraud, Helene
    Barbier, Louise
    Salame, Ephrem
    HEPATOLOGY, 2021, 73 (06) : 2615 - 2616
  • [25] Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A
    Voloshyna, Iryna
    Teboul, Isaac
    Kasselman, Lora J.
    Salama, Michael
    Carsons, Steven E.
    DeLeon, Joshua
    Mattana, Joseph
    Miyawaki, Nobuyuki
    Reiss, Allison B.
    INFLAMMATION RESEARCH, 2019, 68 (09) : 787 - 799
  • [26] Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A
    Iryna Voloshyna
    Isaac Teboul
    Lora J. Kasselman
    Michael Salama
    Steven E. Carsons
    Joshua DeLeon
    Joseph Mattana
    Nobuyuki Miyawaki
    Allison B. Reiss
    Inflammation Research, 2019, 68 : 787 - 799
  • [27] Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and Immunosuppressive Drugs: Causality of Mycophenolate Mofetil or Tacrolimus? REPLY
    Poli, Edoardo
    Verstuyft, Celine
    Guettier, Catherine
    Duclos Vallee, Jean-Charles
    HEPATOLOGY, 2021, 73 (06) : 2616 - 2616
  • [28] Mycophenolate mofetil and tacrolimus: New therapeutic options in neuroimmunological diseases
    Schneider-Gold, Christiane
    Hartung, Hans-Peter
    Gold, Ralf
    MUSCLE & NERVE, 2006, 34 (03) : 284 - 291
  • [29] Mycophenolate mofetil is superior in combination with tacrolimus compared to cyclosporine for immunosuppressive therapy after liver transplantation
    Glanemann, M
    Klupp, J
    Langrehr, JM
    Platz, KP
    Schröer, G
    Raakow, R
    Stange, B
    Settmacher, U
    Bechstein, WO
    Neuhaus, P
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1069 - 1070
  • [30] Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation
    Miki, T
    Goller, A
    Rao, A
    Wang, X
    Yin, WY
    Tandin, A
    Fung, JJ
    Starzl, TE
    Valdivia, LA
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1091 - 1092
12345